Cargando…

Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease

Extracellular vesicles (EVs) are nanosized vesicles released by almost all body tissues, representing important mediators of cellular communication, and are thus promising candidate biomarkers for neurodegenerative diseases like Alzheimer’s disease (AD). The aim of the present study was to isolate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Visconte, Caterina, Fenoglio, Chiara, Serpente, Maria, Muti, Paola, Sacconi, Andrea, Rigoni, Marta, Arighi, Andrea, Borracci, Vittoria, Arcaro, Marina, Arosio, Beatrice, Ferri, Evelyn, Golia, Maria Teresa, Scarpini, Elio, Galimberti, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572781/ https://www.ncbi.nlm.nih.gov/pubmed/37834197 http://dx.doi.org/10.3390/ijms241914749

Ejemplares similares

Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia
por: Fenoglio, Chiara, et al.
Publicado: (2022)

MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease
por: Serpente, Maria, et al.
Publicado: (2020)

A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease
por: Arcaro, Marina, et al.
Publicado: (2022)

Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect
por: Visconte, C., et al.
Publicado: (2023)

Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
por: D’Anca, Marianna, et al.
Publicado: (2019)

Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia(1)
por: Fenoglio, Chiara, et al.
Publicado: (2018)

Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic
por: Sacchi, Luca, et al.
Publicado: (2023)

miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia
por: Serpente, Maria, et al.
Publicado: (2022)

Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations
por: Serpente, Maria, et al.
Publicado: (2015)

Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation
por: Arighi, Andrea, et al.
Publicado: (2022)

Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
por: D’Anca, Marianna, et al.
Publicado: (2021)

miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis
por: Scaroni, Federica, et al.
Publicado: (2022)

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
por: Fenoglio, Chiara, et al.
Publicado: (2013)

MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis
por: Fenoglio, Chiara, et al.
Publicado: (2012)

The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis
por: Buccellato, Francesca R., et al.
Publicado: (2022)

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy
por: Arighi, Andrea, et al.
Publicado: (2015)

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study
por: Galimberti, Daniela, et al.
Publicado: (2018)

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis
por: Ridolfi, Elisa, et al.
Publicado: (2013)

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
por: Buccellato, Francesca Romana, et al.
Publicado: (2021)

Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters
por: Arighi, Andrea, et al.
Publicado: (2021)

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes
por: Carandini, Tiziana, et al.
Publicado: (2019)

Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage
por: Pietroboni, Anna M., et al.
Publicado: (2022)

Genetics of Frontotemporal Lobar Degeneration
por: Galimberti, Daniela, et al.
Publicado: (2012)

Cerebrospinal fluid glutamate changes in functional movement disorders
por: Demartini, Benedetta, et al.
Publicado: (2020)

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
por: Saresella, Marina, et al.
Publicado: (2020)

Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease
por: D'Addario, Claudio, et al.
Publicado: (2012)

Alzheimer’s Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study
por: Dolci, Giulia A. M., et al.
Publicado: (2017)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

The Role of the Innate Immune System in Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia
por: Ridolfi, Elisa, et al.
Publicado: (2013)

Progranulin Gene Variability and Plasma Levels in Bipolar Disorder and Schizophrenia
por: Galimberti, Daniela, et al.
Publicado: (2012)

Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy
por: Arnaldi, Dario, et al.
Publicado: (2021)

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2021)

Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease
por: Fumagalli, Giorgio G., et al.
Publicado: (2020)

Lack of Association between the GPR3 Gene and the Risk for Alzheimer's Disease
por: Dominici, Roberto, et al.
Publicado: (2011)

VAMP2 Expression and Genotype Are Possible Discriminators in Different Forms of Dementia
por: Costa, Andrea Saul, et al.
Publicado: (2022)

A Functional Variant in ERAP1 Predisposes to Multiple Sclerosis
por: Guerini, Franca Rosa, et al.
Publicado: (2012)

Biological Frailty Index in centenarians
por: Arosio, Beatrice, et al.
Publicado: (2021)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6nbn16ve1peiv59l028jtt7459